FDA Advisory Committees -  FDA Center for Biologics Evaluation and Research (CBER) - Blood Products Advisory Committee (BPAC)

Upcoming Meetings

Past Meetings

Blood Products Advisory Committee (BPAC)

BPAC reviews and evaluates available data concerning the safety, effectiveness, and appropriate use of the following

  • blood,
  • products derived from blood and serum
  • or biotechnology

which are intended for use in the diagnosis, prevention, or treatment of human diseases, and, as required, any other product for which the FDA has regulatory responsibility, and advises the Commissioner of Food and Drugs of its findings.

FDA Committee Website